231 related articles for article (PubMed ID: 21620948)
21. Mitochondrial glutathione: hepatocellular survival-death switch.
Garcia-Ruiz C; Fernandez-Checa JC
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S3-6. PubMed ID: 16958667
[TBL] [Abstract][Full Text] [Related]
22. Sida rhomboidea.Roxb extract alleviates pathophysiological changes in experimental in vivo and in vitro models of high fat diet/fatty acid induced non-alcoholic steatohepatitis.
Thounaojam MC; Jadeja RN; Dandekar DS; Devkar RV; Ramachandran AV
Exp Toxicol Pathol; 2012 Mar; 64(3):217-24. PubMed ID: 20832268
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes.
De Gottardi A; Spahr L; Ravier-Dall'Antonia F; Hadengue A
Liver Int; 2010 Nov; 30(10):1482-9. PubMed ID: 20602678
[TBL] [Abstract][Full Text] [Related]
24. Gel entrapment culture of rat hepatocytes for investigation of tetracycline-induced toxicity.
Shen C; Meng Q; Schmelzer E; Bader A
Toxicol Appl Pharmacol; 2009 Jul; 238(2):178-87. PubMed ID: 19463838
[TBL] [Abstract][Full Text] [Related]
25. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
26. Biochemical and immunohistochemical analysis of orotic acid-induced fatty liver.
Murakoshi M; Suemizu H; Takekoshi S; Misawa M; Watanabe K
Tokai J Exp Clin Med; 1991 Oct; 16(3-4):197-201. PubMed ID: 1811353
[TBL] [Abstract][Full Text] [Related]
27. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
Pan M; Song YL; Xu JM; Gan HZ
J Pineal Res; 2006 Aug; 41(1):79-84. PubMed ID: 16842545
[TBL] [Abstract][Full Text] [Related]
28. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
29. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
Allard JP; Aghdassi E; Mohammed S; Raman M; Avand G; Arendt BM; Jalali P; Kandasamy T; Prayitno N; Sherman M; Guindi M; Ma DW; Heathcote JE
J Hepatol; 2008 Feb; 48(2):300-7. PubMed ID: 18086506
[TBL] [Abstract][Full Text] [Related]
30. Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells.
Wu CH; Lin MC; Wang HC; Yang MY; Jou MJ; Wang CJ
J Food Sci; 2011 Mar; 76(2):T65-72. PubMed ID: 21535797
[TBL] [Abstract][Full Text] [Related]
31. [The relationship between the opening of mitochondrial permeability transition pores of cultured hepatocytes with their apoptoses in a non-alcoholic fatty liver disease model].
Chen DF; Wang CH
Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):837-9. PubMed ID: 18073067
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of the Y220C mutant p53 against steatosis: good news?
Gori M; Barbaro B; Arciello M; Maggio R; Viscomi C; Longo A; Balsano C
J Cell Physiol; 2014 Sep; 229(9):1182-92. PubMed ID: 24395441
[TBL] [Abstract][Full Text] [Related]
33. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
34. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Samy W; Hassanian MA
Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
[TBL] [Abstract][Full Text] [Related]
35. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes.
Joshi-Barve S; Barve SS; Amancherla K; Gobejishvili L; Hill D; Cave M; Hote P; McClain CJ
Hepatology; 2007 Sep; 46(3):823-30. PubMed ID: 17680645
[TBL] [Abstract][Full Text] [Related]
36. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients.
Malaguarnera L; Madeddu R; Palio E; Arena N; Malaguarnera M
J Hepatol; 2005 Apr; 42(4):585-91. PubMed ID: 15763346
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine A and palmitic acid treatment synergistically induce cytotoxicity in HepG2 cells.
Luo Y; Rana P; Will Y
Toxicol Appl Pharmacol; 2012 Jun; 261(2):172-80. PubMed ID: 22521608
[TBL] [Abstract][Full Text] [Related]
38. The effect of oleic and palmitic acid on induction of steatosis and cytotoxicity on rat hepatocytes in primary culture.
Moravcová A; Červinková Z; Kučera O; Mezera V; Rychtrmoc D; Lotková H
Physiol Res; 2015; 64(Suppl 5):S627-36. PubMed ID: 26674288
[TBL] [Abstract][Full Text] [Related]
39. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes.
Schultz Moreira AR; Rüschenbaum S; Schefczyk S; Hendgen-Cotta U; Rassaf T; Broering R; Hardtke-Wolenski M; Buitrago-Molina LE
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167328
[TBL] [Abstract][Full Text] [Related]
40. Pyrrolizidine alkaloid clivorine induced oxidative injury on primary cultured rat hepatocytes.
Ji L; Liu T; Wang Z
Hum Exp Toxicol; 2010 Apr; 29(4):303-9. PubMed ID: 20144959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
